(Q41611055)

5 October 2017

1 reference

title

Can deposition of amyloid be prevented in Alzheimer's disease? (English)

1 reference

5 October 2017

0 references

Kisilevsky R

1

1 reference

5 October 2017

language of work or name

English

0 references

publication date

1 September 1997

1 reference

Annals of the New York Academy of Sciences

5 October 2017

published in

1 reference

5 October 2017

volume

826

1 reference

5 October 2017

page(s)

117-127

1 reference

The characterization of soluble amyloid prepared in water

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48465.X

Direct evidence for circulating apoSAA as the precursor of tissue AA amyloid deposits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48465.X

Amyloid protein SAA is associated with high density lipoprotein from human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48465.X

Evidence for increased amyloid enhancing factor activity in Alzheimer brain extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48465.X

A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48465.X

Circular-dichroism studies on two murine serum amyloid A proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48465.X

Theme and variations on a string of amyloid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48465.X

The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48465.X

Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48465.X

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48465.X

Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of beta-amyloid in rat PC12 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48465.X

Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48465.X

Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48465.X

The toxicity in vitro of beta-amyloid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48465.X

Amyloid beta-protein and the genetics of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48465.X

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48465.X

10.1111/J.1749-6632.1997.TB48465.X

21 January 2018

Identifiers

DOI

1 reference

5 October 2017

1 reference